ADIL
ADIAL PHARMACEUTICALS, INC.
+0.14 (+2.67%)5.38USD12.6K成交股數14.1M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 440K | 433K | 620K | 521K | 732K | 747K | 1.0M | 1.0M | 454K | −46K | 207K | 430K |
| 銷售管理費用 | 5.4M | 1.6M | 1.3M | 1.2M | 1.2M | 1.5M | 1.2M | 1.3M | 1.4M | 1.2M | 1.2M | 1.0M |
| 營業利益 | −52.0M+2664% | −2.0M-12% | −1.9M-15% | −1.8M-23% | −1.9M+2% | −2.3M+100% | −2.2M+63% | −2.3M+55% | −1.8M | −1.1M | −1.4M | −1.5M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −52.0M+2555% | −2.0M-9% | −7.98T+363992194% | −1.8M-27% | −2.0M-70% | −2.2M-100% | −2.2M+58% | −2.5M-326% | −6.5M | −5.12T | −1.4M | 1.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -11.25+144% | -1.48-83% | 1.28-437% | -0.08-86% | -4.61+111% | -8.52+161% | -0.38-68% | -0.59-161% | -2.19 | -3.27 | -1.18 | 0.96 |
| 稀釋股數 | 4.6M | 1.4M | 669K | 22.2M | 425K | 262K | 5.8M | 4.2M | 3.0M | 1.4M | 1.2M | 1.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 28.7M | 4.6M | 5.9M | 4.6M | 5.9M | 2.4M | 5.2M | 3.3M | 5.0M | 2.8M | 316K | 1.2M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 29.1M | 5.2M | 6.7M | 5.7M | 6.8M | 3.5M | 6.7M | 4.9M | – | 4.7M | 2.9M | 3.8M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 28.9M | 1.5M | 1.4M | 1.2M | 1.2M | 1.3M | 829K | 672K | – | 653K | 528K | 462K |
| 股東權益 | −38.4M | 3.7M | 5.3M | 4.5M | 5.6M | 2.1M | 5.9M | 4.3M | 6.1M | 4.1M | 2.3M | 3.3M |
| 負債比 | 99.5% | 28.9% | 20.9% | 20.4% | 17.8% | 38.4% | 12.4% | 13.6% | – | 13.8% | 18.4% | 12.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.6M+2% | – | – | – | −1.6M | – | – | −1.6M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −7.98T | –% | -11.93 | – |
| FY2024 | – | – | −13.20T | –% | -68.01 | – |
| FY2023 | – | – | −5.12T | –% | -3.60 | – |
| FY2022 | – | – | −12.7M | –% | -12.71 | – |
| FY2021 | – | – | −19.4M | –% | -1.04 | −12.0M |
| FY2020 | – | – | −10.9M | –% | -0.87 | – |
| FY2019 | – | – | −8.6M | –% | -0.87 | – |
| FY2018 | – | – | −11.6M | –% | -2.44 | – |